Register
Login:
Share:
Email Facebook Twitter


James Bevan on cybersecurity, banks and the housing market


Valirx Share Chat (VAL)



Share Price: 2.225Bid: 2.15Ask: 2.30Change: 0.075 (+3.49%)Riser - Valirx
Spread: 0.15Spread as %: 6.98%Open: 2.25High: 2.25Low: 2.15Yesterday’s Close: 2.15


Share Discussion for Valirx


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Obelix
Posts: 10,502
Off Topic
Opinion:No Opinion
Price:2.225
Guys
Today 12:33
Why those small Sell trades here? Any ideia?
 
Arbitrage
Posts: 1,087
Observation
Opinion:No Opinion
Price:2.20
courtesy of: proactiveinvestors . .
Today 10:35
Noise
Posts: 1,992
Off Topic
Opinion:No Opinion
Price:2.20
View Thread (2)
Patent
Today 10:22
This is the Australian patent discussed today. Beware: requires a degree level of medical training, and/or technical persistence. However there are some nice overviews of the androgen/HSD10 enzyme relationship to common cancers, and how/why VAL401 would work.

https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20161124&DB=&locale=&CC=AU&NR=2015257594A1&KC=A1&ND=1

Page 59 (or 60/76 from the selection) gets interesting about the lab testing. From sentence [0144] it basically says in the petri dish it was effective at killing: 60% of PC3 prostate cancer growths, 100% of A549 lung cancer growths, 70% of MCF7 cancer (I think this is breast cancer? not entirely sure).

In the mice models it seems to prevent 50-70% of tumour growth, although not quite as much as chemotherapy, although chemo had serious repercussions on other aspects of animal health. Differences between body/petri dish behaviour is to be expected.

So if you want to know what your investments are doing....there's a good way to cut through some of the ambiguity.
fourteen14
Posts: 518
Observation
Opinion:Buy
Price:2.15
Licensing
Today 10:03
I am sure when the results come through, there will be lots of updates. wont be long now.
MrMole
Posts: 166
Observation
Opinion:Hold
Price:2.25
Licensing
Today 09:56
The comment about licensing discussions has been included in previous RNS's. It's still good news and would be helpful (and encouraging to PI's) if hey would give some update on the progress.
fourteen14
Posts: 518
Observation
Opinion:Buy
Price:2.25
MITHUN
Today 09:52
Lots of news to come.....!!
Mithun
Posts: 440
Off Topic
Opinion:No Opinion
Price:2.25
RE: MITHUN
Today 09:46
Looks very promising
Mithun
Posts: 440
Off Topic
Opinion:No Opinion
Price:2.25
RE: MITHUN
Today 09:46
Found it thanks.... The group is already in licensing discussions with major players in the oncology field.

ValiRx's two classes of drugs in development, which each have the potential for meeting hitherto unmet medical needs by existing methods, have worldwide patent filings and agreed commercial rights.
fourteen14
Posts: 518
Observation
Opinion:Buy
Price:2.25
MITHUN
Today 09:40
Read the notes at bottom of RNS......"the group are already in licensing discussions with MAJOR players in the oncology field".
Noise
Posts: 1,992
Off Topic
Opinion:No Opinion
Price:2.25
RE: Major deal ahead
Today 09:38
I have to say, I had a deep breath when I saw the VAL RNS release notification come up this morning, just prior to the AGM!




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.